Shorts

1:01
Alex Tatem, MD, outlines the safety of hyaluronic acid penile injections
4 months ago
by
Alex Tatem, MD

0:55
What are some benefits of multiport robotic partial nephrectomy?
4 months ago
by
Savannah Grandy, DO

0:54
The evolution of testicular cancer survivorship care
4 months ago
by
Francisco Ramos, MD

1:07
How Break Wave allows for patient participation in kidney stone treatment
4 months ago
by
Mathew D. Sorensen, MD, MS

1:15
Christopher Filson, MD, shares data on study of CxBladder Triage
4 months ago
by
Christopher P. Filson, MD, MS

1:22
Veda Giri, MD, on patient education for genetic testing
4 months ago
by
Veda N. Giri, MD

1:01
Amy Luckenbaugh, MD, on advances in urologic oncology
4 months ago
by
Amy N. Luckenbaugh, MD

4:24
World Cancer Day: Honoring Patient Resilience and Recent Advances in Urologic Oncology
4 months ago
by
Hannah Clarke

1:11
Kate Kraft, MD, discusses how to build leadership presence as an introvert
4 months ago
by
Kate H. Kraft, MD, MHPE, FACS, FAAP

1:02
Amanda North, MD, discusses imposter syndrome and reframing your thinking
4 months ago
by
Amanda C. North, MD

1:12
Mathew D. Sorensen, MD, MS, FACS, on how Break Wave lithotripsy works without anesthesia
4 months ago
by
Mathew D. Sorensen, MD, MS

1:07
Farah Rahman, MD, discusses wearable tech in measuring burnout
5 months ago
by
Farah Rahman, MD, MPH

1:15
Ridwan I. Alam, MD, MPH, on PHI’s role in prostate cancer risk stratification
5 months ago
by
Ridwan I. Alam, MD, MPH

1:00
Aleece Fosnight, MSPAS, PA-C, on how vaginal estrogen cream helps patients
5 months ago
by
Aleece Fosnight, MSPAS, PA-C, CSC-S, CSE, IF, MSCP, HAES

0:51
The UroOnc Minute: Adam Weiner, MD, and Jeremy Teoh, MBBS, on en bloc resection of bladder tumor
5 months ago
by
Adam B. Weiner, MD(+1 more)

0:55
Sudha Jayaraman, MD, on how AI can help mitigate physician burnout
5 months ago
by
Sudha Jayaraman, MD, MSc, FACS

0:48
Daniel Antonio González Padilla, MD, on the end points of the CREST and POTOMAC trials
5 months ago
by
Daniel Antonio González Padilla, MD

1:14
Ridwan I. Alam, MD, MPH, on his approach to prostate cancer screening
5 months ago
by
Ridwan I. Alam, MD, MPH

1:04
Kalyani Narra, MD, outlines gaps in referrals for genetic counseling in prostate cancer
5 months ago
by
Kalyani Narra, MD

1:09
Aleece Fosnight, MSPAS, PA-C, on hydration and pelvic floor physical therapy for bladder symptoms
5 months ago
by
Aleece Fosnight, MSPAS, PA-C, CSC-S, CSE, IF, MSCP, HAES

1:15
Archan Khandekar, MD, discusses the use of augmented reality with prostate biopsy
5 months ago
by
Archan Khandekar, MD

0:53
Aleece Fosnight, MSPAS, PA-C, on evaluating cyclical bladder symptoms in women
5 months ago
by
Aleece Fosnight, MSPAS, PA-C, CSC-S, CSE, IF, MSCP, HAES

0:35
Sevann Helo, MD, shares her advice for urology residency applicants
5 months ago
by
Sevann Helo, MD

1:08
Pearls & Perspectives: Amy Pearlman, MD, and Nicoletta Heidegger, MA, MEd, LMFT, on sexual medicine myths
5 months ago
by
Amy M. Pearlman, MD

1:24
Jennifer Miles-Thomas, MD, URPS, MBA, on academic care centers expanding into communities
5 months ago
by
Jennifer Miles-Thomas, MD, URPS, MBA

1:19
Ridwan I. Alam, MD, MPH, on the PHI test in men with PSA between 10 and 20 ng/mL
5 months ago
by
Ridwan I. Alam, MD, MPH

1:08
The Expert APProach: Jennifer Bepple, MD, MMCi, on how APPs enhance patient care
5 months ago
by
Joy Maulik, CRNP

1:07
Bruno Nahar, MD, on the urologic oncology program at Urology on the Beach
5 months ago
by
Bruno Nahar, MD

1:22
The Expert APProach: What Led Jennifer Bepple, MD, MMCi, to Digital Health
5 months ago
by
Joy Maulik, CRNP

1:08
Pearls & Perspectives: Advice for Patients on Disclosing STIs
5 months ago
by
Amy M. Pearlman, MD
Advertisement
Advertisement
Trending on Urology Times
1
FDA approves capivasertib plus abiraterone and prednisone for PTEN-deficient mHSPC
2
Toni Choueiri, MD, reacts to FDA approval of adjuvant belzutifan with pembrolizumab for ccRCC
3
Dean Elterman, MD, highlights efficacy and safety data on the Zenflow Prostatic Spring
4
FDA approves adjuvant belzutifan with pembrolizumab for ccRCC
5
